Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas

BACKGROUND: Triple negative breast cancer (TNBC) in humans is defined by the absence of oestrogen receptor (ER), progesterone receptor (PR) and HER2 overexpression. Mammalian target of rapamycin (mTOR) is overexpressed in TNBC and it represents a potential target for the treatment of this aggressive...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Maniscalco, Lorella, Millán, Yolanda, Iussich, Selina, Denina, Mauro, Sánchez-Céspedes, Raquel, Gattino, Francesca, Biolatti, Bartolomeo, Sasaki, Nobuo, Nakagawa, Takayuki, Di Renzo, Maria Flavia, de las Mulas, Juana Martín, De Maria, Raffaella
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2013
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3637810/
https://ncbi.nlm.nih.gov/pubmed/23587222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-6148-9-80
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares